ArticleFrontiers in immunology2026

Real-world efficacy of eculizumab in generalized myasthenia gravis patients with poor early response to efgartigimod: a prospective cohort study.

Xueting An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.